Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use TRUMENBA safely and effectively. See full prescribing information for TRUMENBA. TRUMENBA® (Meningococcal Group B Vaccine)Suspension for intramuscular injectionInitial U.S. Approval: 2014
Medication labelWhy this: Advisory · dailymed-other
Trumenba is indicated for active immunization to prevent invasive disease caused by Neisseria meningitidis serogroup B. Trumenba is approved for use in individuals 10 through 25 years of age.
- generic_name
- meningococcal group b vaccine
- product_names
- meningococcal group B vaccine
- ndc
- 0005-0100, 0005-0100-01, 0005-0100-05, 0005-0100-10
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en